These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8394911

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Side chain methyl substitution in the delta-opioid receptor antagonist TIPP has an important effect on the activity profile.
    Tourwé D, Mannekens E, Diem TN, Verheyden P, Jaspers H, Tóth G, Péter A, Kertész I, Török G, Chung NN, Schiller PW.
    J Med Chem; 1998 Dec 17; 41(26):5167-76. PubMed ID: 9857087
    [Abstract] [Full Text] [Related]

  • 23. Conformationally restricted deltorphin analogues.
    Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN, Lemieux C.
    J Med Chem; 1992 Oct 16; 35(21):3956-61. PubMed ID: 1331451
    [Abstract] [Full Text] [Related]

  • 24. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects.
    Szekeres PG, Traynor JR.
    J Pharmacol Exp Ther; 1997 Dec 16; 283(3):1276-84. PubMed ID: 9400003
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Structure-activity relationships for SNC80 and related compounds at cloned human delta and mu opioid receptors.
    Knapp RJ, Santoro G, De Leon IA, Lee KB, Edsall SA, Waite S, Malatynska E, Varga E, Calderon SN, Rice KC, Rothman RB, Porreca F, Roeske WR, Yamamura HI.
    J Pharmacol Exp Ther; 1996 Jun 16; 277(3):1284-91. PubMed ID: 8667189
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dynorphin A(1-8): stability and implications for in vitro opioid activity.
    Bell KM, Traynor JR.
    Can J Physiol Pharmacol; 1998 Mar 16; 76(3):325-33. PubMed ID: 9673796
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers.
    Schiller PW, Nguyen TM, Lemieux C, Maziak LA.
    J Med Chem; 1985 Dec 16; 28(12):1766-71. PubMed ID: 2999401
    [Abstract] [Full Text] [Related]

  • 32. Site-directed alkylation of multiple opioid receptors. II. Pharmacological selectivity.
    Goldstein A, James IF.
    Mol Pharmacol; 1984 May 16; 25(3):343-8. PubMed ID: 6328260
    [Abstract] [Full Text] [Related]

  • 33. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique delta and mu opioid activity in modified peptides.
    Breveglieri A, Guerrini R, Salvadori S, Bianchi C, Bryant SD, Attila M, Lazarus LH.
    J Med Chem; 1996 Feb 02; 39(3):773-80. PubMed ID: 8576920
    [Abstract] [Full Text] [Related]

  • 34. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
    Stewart PE, Hammond DL.
    J Pharmacol Exp Ther; 1993 Aug 02; 266(2):820-8. PubMed ID: 8394918
    [Abstract] [Full Text] [Related]

  • 35. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
    Pencheva N, Bocheva A, Dimitrov E, Ivancheva C, Radomirov R.
    Eur J Pharmacol; 1996 May 23; 304(1-3):99-108. PubMed ID: 8813590
    [Abstract] [Full Text] [Related]

  • 36. Antinociceptive activity of [beta-methyl-2', 6'-dimethyltyrosine(1)]-substituted cyclic [D-Pen(2), D-Pen(5)]Enkephalin and [D-Ala(2),Asp(4)]Deltorphin analogs.
    Bilsky EJ, Qian X, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 2000 Apr 23; 293(1):151-8. PubMed ID: 10734164
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Development of a model for the delta opioid receptor pharmacophore. 1. Conformationally restricted Tyr1 replacements in the cyclic delta receptor selective tetrapeptide Tyr-c[D-Cys-Phe-D-Pen]OH (JOM-13).
    Mosberg HI, Lomize AL, Wang C, Kroona H, Heyl DL, Sobczyk-Kojiro K, Ma W, Mousigian C, Porreca F.
    J Med Chem; 1994 Dec 09; 37(25):4371-83. PubMed ID: 7996549
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.